These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22637747)

  • 1. Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations.
    Sequeiros IM; Jarad NA
    Chron Respir Dis; 2012; 9(4):213-20. PubMed ID: 22637747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis.
    Sequeiros IM; Jarad N
    Chron Respir Dis; 2012 Feb; 9(1):9-16. PubMed ID: 22308550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.
    Nazer D; Abdulhamid I; Thomas R; Pendleton S
    Pediatr Pulmonol; 2006 Aug; 41(8):744-9. PubMed ID: 16779852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis.
    Wagener JS; Rasouliyan L; VanDevanter DR; Pasta DJ; Regelmann WE; Morgan WJ; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):666-73. PubMed ID: 22888106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
    Heltshe SL; Goss CH; Thompson V; Sagel SD; Sanders DB; Marshall BC; Flume PA
    Thorax; 2016 Mar; 71(3):223-9. PubMed ID: 25911223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM; McGaw J; Taylor CJ; Everard ML
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections.
    Termoz A; Touzet S; Bourdy S; Decullier E; Bouveret L; Colin C; Nove-Josserand R; Reix P; Cracowski C; Pin I; Bellon G; Durieu I
    Pediatr Pulmonol; 2008 Sep; 43(9):908-15. PubMed ID: 18680182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue in cystic fibrosis: a novel prospective study investigating subjective and objective factors associated with fatigue.
    Jarad NA; Sequeiros IM; Patel P; Bristow K; Sund Z
    Chron Respir Dis; 2012; 9(4):241-9. PubMed ID: 23129802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic sinus surgery in adults with cystic fibrosis: effect on lung function, intravenous antibiotic use, and hospitalization.
    Henriquez OA; Wolfenden LL; Stecenko A; Delgaudio JM; Wise SK
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1167-70. PubMed ID: 23247236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic duration and changes in FEV
    Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
    BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel respiratory symptom scoring system for CF pulmonary exacerbations.
    Jarad NA; Sequeiros IM
    QJM; 2012 Feb; 105(2):137-43. PubMed ID: 21908385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria.
    Block JK; Vandemheen KL; Tullis E; Fergusson D; Doucette S; Haase D; Berthiaume Y; Brown N; Wilcox P; Bye P; Bell S; Noseworthy M; Pedder L; Freitag A; Paterson N; Aaron SD
    Thorax; 2006 Nov; 61(11):969-74. PubMed ID: 16844728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.
    Saiman L; Mayer-Hamblett N; Campbell P; Marshall BC;
    Am J Respir Crit Care Med; 2005 Oct; 172(8):1008-12. PubMed ID: 16040785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
    Sanders DB; Solomon GM; Beckett VV; West NE; Daines CL; Heltshe SL; VanDevanter DR; Spahr JE; Gibson RL; Nick JA; Marshall BC; Flume PA; Goss CH;
    J Cyst Fibros; 2017 Sep; 16(5):592-599. PubMed ID: 28460885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects.
    Wolter JM; Bowler SD; Nolan PJ; McCormack JG
    Eur Respir J; 1997 Apr; 10(4):896-900. PubMed ID: 9150331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
    West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
    J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
    Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Kronman MP; Rosenfeld M; Nichols DP
    Ann Am Thorac Soc; 2021 Feb; 18(2):266-272. PubMed ID: 32810412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.